Cargando…

MYOCARDITIS LINKED TO PFIZER-BIONTECH COVID-19 VACCINE

Detalles Bibliográficos
Autores principales:	PRATAP SINGH, VIJAY, SIDDIQUE PIR, MUHAMMAD, BUCH, TAPAN, KAUR, AMANDEEP, KELA, KASHYAP, SHAH, PRINCY, MILLER, JACOB, NASEER, RAZA, GHOSH, PRADEEPTO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503352/ http://dx.doi.org/10.1016/j.chest.2021.07.437

Ejemplares similares

COVID-19-INDUCED EVANS SYNDROME: UNUSUAL COMPLICATION OF THE NEW USUAL
por: SHAH, PRINCY, et al.
Publicado: (2022)

CORONAVIRUS-INDUCED MYOCARDITIS REQUIRING BI-VENTRICULAR ASSIST DEVICE
por: Papukhyan, Hayk, et al.
Publicado: (2020)

COVID-19-ASSOCIATED MYOCARDITIS MIMICKING ST ELEVATION MYOCARDIAL INFARCTION
por: Mustafa, Syed, et al.
Publicado: (2020)

AN INTERESTING CASE OF DELAYED ONSET MYOCARDITIS FOLLOWING COVID-19 INFECTION
por: SIDDIQUI, MOHAMMED, et al.
Publicado: (2021)

FULMINANT MYOCARDITIS IN A PATIENT WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2
por: Tavares, Matthew, et al.
Publicado: (2020)

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Myocarditis: 7 case reports
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Acute myocarditis: case report
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Hypersensitivity myocarditis: case report
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Myocarditis: 4 case reports
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Myocarditis: case report
Publicado: (2022)

Covid-19-vaccine-pfizer-biontech: Lymphocytic myocarditis: case report
Publicado: (2021)

Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Publicado: (2022)

Covid-19-vaccine-pfizer-biontech: Acute peri-myocarditis: case report
Publicado: (2022)

COVID-19 Vaccine Pfizer BioNTech: Acute myocarditis: case report
Publicado: (2022)

COVID-19 vaccine Pfizer BioNTech: Recurrence of acute myocarditis: case report
Publicado: (2021)

A case of myocarditis and isolated hypopotassemia after Biontech-Pfizer vaccine for Covid-19
por: Ceylan, Mehmet Emin, et al.
Publicado: (2022)

COMPLICATIONS OF HIGH-DOSE STEROIDS IN COVID-19
por: KAUR, TANISHA, et al.
Publicado: (2021)

CLINICAL OUTCOMES ASSOCIATED WITH IVERMECTIN USE IN COVID-19: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
por: KARALE, SMRUTI, et al.
Publicado: (2021)

A CASE OF COVID-19 PRESENTING WITH ENCEPHALOPATHY, POST-INFECTIOUS NEUROPSYCHIATRIC SEQUELAE, AND ACCELERATED WORSENING OF CHRONIC COMORBIDITIES
por: DAGOGO-JACK, IBIMINA, et al.
Publicado: (2021)

ORAL MANIFESTATIONS OF COVID-19 INFECTION: AN ANALYTICAL CROSS SECTIONAL STUDY
por: CHAUDHRY, K., et al.
Publicado: (2022)

INADEQUATE IMMUNE RESPONSE TO COVID-19 VACCINES IN THE PRESENCE OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS)
por: KRISHNAIAH, AISHWARYA, et al.
Publicado: (2022)

PLASMA EXCHANGE IN THE TREATMENT OF THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH COVID-19 INFECTION: A CASE REPORT
por: Logan, Danielle, et al.
Publicado: (2020)

A CASE OF SARS-COV-2 ASSOCIATED WITH QUADRUPLE BACTERIAL COINFECTION
por: JIMENEZ, KATIRIA PINTOR, et al.
Publicado: (2022)

FULMINANT MYOCARDITIS AND MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN, IN THE LIGHT OF CORONA VIRUS
por: Singh, Vijay Pratap, et al.
Publicado: (2021)

TB REACTIVATION FOLLOWING COVID-19 INFECTION
por: COLBY, STEVEN, et al.
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Multisystem inflammatory syndrome and myocarditis: case report
Publicado: (2022)

PROTEINACEOUS COVID-19
por: Chandna, Sanya, et al.
Publicado: (2020)

MEASUREMENT OF PATIENT-REPORTED OUTCOMES AT APPROXIMATELY ONE MONTH FOLLOWING A HOSPITAL OR ED DISCHARGE FOR COVID-19
por: CARPE, S., et al.
Publicado: (2022)

TRAJECTORY OF MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA RATINGS IN PATIENTS WITH COVID-19 DISCHARGED FOLLOWING A HOSPITALIZATION OR ED ENCOUNTER
por: MICHALOPOULOS, C., et al.
Publicado: (2022)

HEART HALF FULL
por: SHAH, NIRVI, et al.
Publicado: (2021)

D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)

JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
por: KHANAM, RUKHSAAR, et al.
Publicado: (2022)

PNEUMOTHORAX IN PATIENTS WITH COVID-19 PNEUMONIA NOT ON POSITIVE PRESSURE VENTILATION: A SYSTEMATIC REVIEW OF CASE REPORTS AND SERIES
por: PATTUPARA, ARCHANA, et al.
Publicado: (2021)

POST-COVID-19 EOSINOPHILIC PNEUMONIA
por: SHAH, DHIRAJ, et al.
Publicado: (2022)

RETROSPECTIVE ANALYSIS OF PULMONARY FUNCTION DURING THE POSTACUTE SEQUELAE OF SARS-COV-2 INFECTION
por: DIPOLLINA, CHRISTOPHER, et al.
Publicado: (2022)

3RD DEGREE HEART BLOCK IN A PATIENT WITH CORONA VIRUS
por: Singh, Vijay Pratap, et al.
Publicado: (2021)

First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain
por: Chachar, Tarique S, et al.
Publicado: (2021)

Recurrent MRI-documented myocarditis following Pfizer-BioNTech SARS-CoV-2 vaccination
por: Bucur, Philip, et al.
Publicado: (2022)

ABO BLOOD TYPES AND INFLAMMATORY MARKERS IN COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_30l7134fdo1ua95eflv3gesg4e